Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000482815 | SCV000567243 | likely pathogenic | not provided | 2017-01-25 | criteria provided, single submitter | clinical testing | The H1485R variant in the TAF1 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The H1485R variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The H1485R variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. However, this substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret H1485R is a strong candidate for a pathogenic variant. |
Genome Medicine, |
RCV001027760 | SCV000998778 | likely pathogenic | Intellectual disability, X-linked, syndromic 33 | 2019-09-23 | no assertion criteria provided | clinical testing | |
Yale Center for Mendelian Genomics, |
RCV001849379 | SCV002106740 | association | Heart, malformation of | 2020-06-13 | no assertion criteria provided | literature only |